The FDA warns that longtime users of popular allergy medications may experience "severe itching" after stopping use.

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in the United States have come to rely on.

The shift was a marked departure from previous FDA guidance, which recommended an annual COVID vaccine for everyone 6 months and older.

The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under age 65, effectively limiting them to older adults and those at risk of developing severe illness.

The FDA greenlit marketing for the first blood test to help diagnose Alzheimer’s disease. Experts believe this will increase access to Alzheimer’s detection and reduce reliance on expensive PET scans and invasive spinal taps.

The Food and Drug Administration (FDA) announced Wednesday plans to help states and Indian tribes import cheaper prescription drugs from Canada. The initiative is in support of President Donald Trump’s executive order on May 12 which promised to deliver “most-favored nation prescription drug pricing” to America,